BioPharm
I N T E R N AT I O N A L
eBook
T h e S ci e n ce & B usi n e ss o f B i o p h a r m a ce u t i c a ls
FOUNDER
Mike Hennessy Sr
1960 - 2021
© 2024 MultiMedia Pharma Sciences LLC All rights reserved. No part of this publication may be
reproduced or transmitted in any form or by any means, electronic or mechanical including by photocopy,
recording, or information storage and retrieval without permission in writing from the publisher. Authorization to
photocopy items for internal/educational or personal use, or the internal/educational or personal use of specific
clients is granted by MultiMedia Pharma Sciences LLC for libraries and other users registered with the Copyright
Clearance Center, 222 Rosewood Dr. Danvers, MA 01923, 978-750-8400 fax 978-646-8700 or visit http://www.
copyright.com online. For uses beyond those listed above, please direct your written request to BPpress@
mmhgroup.com with "Permissions" in the subject line. Reprints: Contact Brian Haug, Bhaug@mmhgroup.com.
MultiMedia Pharma Sciences LLC provides certain customer contact data (such as customers' names,
addresses, phone numbers, and e-mail addresses) to third parties who wish to promote relevant products,
services, and other opportunities that may be of interest to you. If you do not want MultiMedia Pharma Sciences
LLC to make your contact information available to third parties for marketing purposes, simply email mmhinfo@
mmhgroup.com and a customer service representative will assist you in removing your name from MultiMedia
Pharma Sciences LLC lists.
BioPharm International
®
does not verify any claims or other information appearing in any of the
advertisements contained in the publication, and cannot take responsibility for any losses or other damages
incurred by readers in reliance of such content.
BioPharm International welcomes unsolicited articles, manuscripts, photographs, illustrations, and other
materials but cannot be held responsible for their safekeeping or return.
To subscribe, email mmhinfo@mmhgroup.com
Contents
EDITORIAL
Vice President, Content Alicia Bigica ABigica@mjhlifesciences.com
Associate Editorial Director Felicity Thomas FThomas@mjhlifesciences.com
Lead Editor Susan Haigney SHaigney@mjhlifesciences.com
Science Editor Feliza Mirasol FMirasol@mjhlifesciences.com
Editor Patrick Lavery PLavery@mjhlifesciences.com
Contributing editors
Cynthia A. Challener
Design and Production
Creative Director Robert McGarr rmcgarr@mjhlifesciences.com
Senior Art Director Kristen Morabito kmorabito@mjhlifesciences.com
Print and Circulation Director Jonathan Severn jsevern@mjhassoc.com
Production Manager Charlton Prince cprince@mjhlifesciences.com
Print Production Coordinator Amber Immordino ammordino@mjhassoc.com
CUSTOM CONTENT
Director Robert Alaburda
Managing Editor Jeanne Linke Northrop
Senior Editor Megan Manzano
Senior Editor Shannon Stolz
ADVERTISING
National Sales Manager Scott Vail SVail@mjhlifesciences.com
Sales Manager Joel Kern JKern@mjhlifesciences.com
National Account Associate Padraic Finnegan
PFinnegan@mjhlifesciences.com
European Sales Manager Linda Hewitt LHewitt@mjhlifesciences.com
European Senior Sales Executive Stephen Cleland
SCleland@mjhlifesciences.com
Director, Industry Relations and Strategic Partnerships Chris Spivey
CSpivey@mjhlifesciences.com
MJH LIFE SCIENCES
®
President & CEO Mike Hennessy Jr
Chief Financial Officer Neil Glasser, CPA/CFE
Chief Operating Officer Beth Buehler
Chief Data Officer Terric Townsend
Executive Vice President, Global Medical Affairs
& Corporate Development Joe Petroziello
Executive Vice President, Healthcare Brian Haug
Senior Vice President, Content Silas Inman
Senior Vice President, Human Resources
& Administration Shari Lundenberg
Senior Vice President, Mergers & Acquisitions,
Strategic Innovation Phil Talamo
Executive Creative Director Jeff Brown
Emerging Therapies eBook
September 2024
Cover: Anusorn – Stock.Adobe.com
CELL AND GENE THERAPIES
Frontrunners in Automated
Cell and Gene Therapy Manufacturing
Cheryl Barton
Innovative solutions are making personalized
cell and gene therapies accessible to all. 4
CELL LINE DEVELOPMENT
Ensuring Cell Line Stability
for Protein Therapeutics
Roxana McCloskey and Zoe Zhang
Stable cell line development can benefit
from applying integrated analytical technologies. 8
ANTIBODY-DRUG CONJUGATES
Valuing Specialized
Experience in ADC Development
Pamela James
Bringing promising ADC candidates to
market faster hinges on the biopharma
industry investing in linker design capabilities. 16
DEVELOPMENT
The Logistics of Developing
an Emerging Therapy
Susan Haigney
Emerging therapies, such as cell and
gene therapies, come with unique challenges
that must be planned for in advance. 22
INDUSTRY UPDATE
Update on Trends in Emerging
Therapies and Manufacturing
Patrick Lavery
The latest developments in emerging
therapies including new innovations and
collaborative efforts in manufacturing. 28
AD INDEX 30
www.biopharminternational.com Emerging Therapies eBook September 2024 BioPharm International
®
3
